Prescribing parkrun is a retrograde step, argues doctor

General practitioners are now “prescribing" parkrun for their patients as part of a social prescribing initiative to promote preventative care. But in The BMJ today, Dr Margaret McCartney argues that turning parkrun into a prescription medicalises a walk in the park and is a retrograde step. Parkrun is an organised, timed, and ...

2025-04-09T15:40:27+01:009 April 2025|Press release, The BMJ|

Ultrasound during surgery to unblock arteries is a safe and effective way to lower stroke risk

Technique has the potential to improve care for patients with carotid disease, say researchers Using ultrasound during surgery to unblock carotid arteries is a safe and effective way to significantly reduce the risk of stroke and death, finds a trial published by The BMJ today. The technique, called sonolysis, uses continuous ultrasound ...

2025-03-20T10:16:48+00:0020 March 2025|Press release, The BMJ|

Over 1.2 million medical device side-effect reports not submitted within legal timeframe

Late adverse event reporting may prevent early detection of patient safety concerns, warn researchers Over 1.2 million medical device adverse event reports were not submitted to the US Food and Drug Administration (FDA) within the deadline set by federal regulations, finds an analysis of recent data published by The BMJ today. Of ...

2025-03-13T14:13:13+00:0013 March 2025|Press release, The BMJ|

No evidence that substituting NHS doctors with physician associates is necessarily safe

Evidence base on safety and effectiveness of physician associate and anaesthetic associate practice in the UK “sparse and of variable quality” Researchers say they can find no convincing evidence that physician associates add value in UK primary care or that anaesthetic associates add value in anaesthetics, and some evidence suggested ...

2025-03-07T15:16:24+00:007 March 2025|Press release, The BMJ|

Cases of Parkinson’s disease set to reach 25 million worldwide by 2050

Substantial increase largely due to population ageing, say researchers By 2050, there will be 25.2 million people living with Parkinson’s disease worldwide (a 112% increase from 2021), largely due to population ageing, suggests a modelling study published by The BMJ today. Overall, the number of people living with Parkinson’s disease (all age ...

2025-03-05T16:48:52+00:006 March 2025|Press release, The BMJ|

Acting against racism for a healthier, more equal, world

A sustained reduction in a high-risk population In February 2020, The BMJ highlighted the racial discrimination and health inequalities experienced by both patients and doctors in a special 'Racism in medicine' campaigning issue. Its huge success contributed to the launch of the NHS - Race and Health ...

2026-06-04T13:55:05+01:004 March 2025|Our impact, The BMJ|
Go to Top